Foreign travel and decreased ciprofloxacin susceptibility in Salmonella enterica infections

Emerging Infectious Diseases

Volumn 17, Issue 1, 2011, Pages 123-125

  Al Mashhadani, Manar ^a   Hewson, Robert ^a   Vivancos, Roberto ^b,c   Keenan, Alex ^b   Beeching, Nick J ^d   Wain, John ^b   Parry, Christopher M ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; NALIDIXIC ACID; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; GRAM NEGATIVE SEPSIS; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SEROTYPE; TRAVEL; TYPHOID FEVER;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GREAT BRITAIN; HUMANS; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; SALMONELLA ENTERICA; SALMONELLA ENTERITIDIS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; TRAVEL;

EID: 78650978499     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1701.100999     Document Type: Article

References (15)

1. Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis. 2001;32:263-269. DOI: 10.1086/318457
2. Parry CM, Threlfall EJ. Antimicrobial resistance in typhoidal and non-typhoidal salmonellae. Curr Opin Infect Dis. 2008;21:531-538. DOI: 10.1097/QCO.0b013e32830f453a
3. Hakanen AJ, Lindgren M, Huovinen P, Jalava J, Siitonen A, Kotilainen P. New quinolone resistance phenomenon in Salmonella enterica: nalidixic acidsusceptible isolates with reduced fluoroquinolone susceptibility. J Clin Microbiol. 2005;43:5775-5778. DOI: 10.1128/JCM.43.11.5775-5778.2005
4. Crump JA, Kretsinger K, Gay K, Hoekstra RM, Vugia DJ, Hurd S, et al. Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States FoodNet multicentre retrospective cohort study. Antimicrob Agents Chemother. 2008;52:1278-1284. DOI:10.1128/AAC.01509-07
5. Mølbak K, Baggesen DL, Aarestrup FM, Ebbesen JM, Engberg J, Frydendahl K, et al. An outbreak of multidrug-resistant, quinoloneresistant Salmonella enterica serotype Typhimurium DT 104. N Engl J Med. 1999;341:1420-1425. DOI: 10.1056/NEJM199911043411902
6. Helms M, Simonsen J, Mølbak K. Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium. J Infect Dis. 2004;190:1652-1654. DOI: 10.1086/424570
7. Varma JK, Molbak K, Barrett TJ, Beebe JL, Jones TF, Rabatsky-Ehr T, et al. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis. 2005;191:554-561. DOI: 10.1086/427263
8. Mølbak K, Gerner-Smidt P, Wegener HC. Increasing quinolone resistance in Salmonella enterica serotype Enteritidis. Emerg Infect Dis. 2002;8:514-515.
9. Hakanen A, Kotilainen P, Huovinen P, Helenius H, Siitonen A. Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg Infect Dis. 2001;7:996-1003. DOI: 10.3201/eid0706.010613
10. Hakanen AJ, Kotilainen P, Pitkänen S, Huikko S, Siitonen A, Huovinen P. Reduction in fluoroquinolone susceptibility among non-typhoidal strains of Salmonella enterica isolated from Finnish patients. J Antimicrob Chemother. 2006;57:569-572. DOI: 10.1093/jac/dkl002
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement. M100-S20. Wayne (PA): The Institute; 2010.
12. Murray A, Coia JE, Mather H, Brown DJ. Ciprofloxacin resistance in non-typhoidal Salmonella serotypes in Scotland, 1993-2003. J Antimicrob Chemother. 2005;56:110-114. DOI: 10.1093/jac/dki164
13. Meakins S, Fisher IST, Berghold C, Gerner-Smidt P, Tschäpe H, Comican M, et al. Antimicrobial drug resistance in human nontyphoidal Salmonella isolates in Europe 2000-2004: a report from the Enter-net International Surveillance Network. Microb Drug Resist. 2008;14:31-35. DOI: 10.1089/mdr.2008.0777
14. Marimón JM, Gomáriz M, Zigorraga C, Cilla G, Pérez-Trallero E. Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003. Antimicrob Agents Chemother. 2004;48:3789-3793. DOI: 10.1128/AAC.48.10.3789-3793.2004
15. Lee HY, Su LH, Tsai MH, Kim SW, Chang HH, Jung SI, et al. High rate of reduced susceptibility to ciprofloxacin and ceftriaxone among nontyphoidal Salmonella clinical isolates in Asia. Antimicrob Agents Chemother. 2009;53:2696-2699. DOI: 10.1128/AAC.01297-08